NumFin

West Pharmaceutical Services, Inc.

符号: WST

NYSE

368.35

USD

今天的市场价格

  • 47.6063

    市盈率

  • 4.2581

    PEG比率

  • 26.83B

    MRK市值

  • 0.00%

    DIV收益率

West Pharmaceutical Services, Inc. (WST) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 West Pharmaceutical Services, Inc. (WST). 的默认数据。公司收入显示 960.931 M 的平均值，即 0.076 % 增长率。整个期间的平均毛利润为 323.508 M，即 0.087 %. 平均毛利率为 0.328 %. 公司去年的净收入增长率为 0.013 %，等于 0.215 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 West Pharmaceutical Services, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.059. 在流动资产领域，WST 的报告货币为1936.4. 这些资产中的很大一部分，即 853.9 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.045%. 公司的长期投资虽然不是其重点，但以报告货币计算的210（如果有的话）为210。这表明与上一报告期相比，2.489% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 157.3. 这一数字表明，-0.028% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 2881. 这方面的年同比变化率为 0.073%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为512，存货估值为 434.7，商誉估值为 108.5（如有. 无形资产总额（如果有）按 15.1 估值.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985

balance-sheet.row.cash-and-short-term-investments

3150.6853.9894.3762.6
615.5
439.1
337.4
235.9
203
274.6
255.3
237.5
174.3
91.8
110.2
83.1
91.5
129.4
47.1
48.8
68.8
37.8
33.2
42.1
42.7
45.3
31.3
52.3
27.4
17.4
27.2
5.2
3
2.7
2.2
1.6
5.1
12.7
7.4
8.5

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
7.5
12.4
0
0
0
4.3
21
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

2089.5512507.4489
385.3
319.3
288.2
253.2
200.5
181.4
179
185.7
175
147.2
126.4
138.7
128.6
136.1
110.5
107.4
75.1
114.9
66.2
61.8
60.9
74.6
64.4
60.4
69.3
67.9
57.8
43.3
41.9
42.8
41.8
44
44.1
35.4
33.4
23.3

balance-sheet.row.inventory

1745.8434.7414.8378.4
321.3
235.7
214.5
215.2
199.3
181.1
181.5
176.9
162.2
151.8
147
129.2
115.7
111.8
97.5
61.2
56.7
48
41.3
34.3
41
42.1
43.5
38.3
44
48.3
38.1
34.5
38
33.8
46.4
44.7
42.8
36.7
34.7
23.5

balance-sheet.row.other-current-assets

489.9135.8103112
51.6
64.6
54.3
39.2
39.1
36.6
35.7
34.7
38.1
73.3
42.5
38.4
25.3
29.7
21.3
17.4
17.7
9.9
15.4
17.9
28.5
22.7
20.5
19.7
16
14.8
13.6
10.2
15.8
18.1
10.8
7.1
4.5
5.1
3
1.2

balance-sheet.row.total-current-assets

7475.81936.41919.51742
1373.7
1058.7
894.4
743.5
641.9
673.7
659.3
650.7
557.3
472
436.6
397.2
366.2
412.3
281.7
237.2
226.5
216.7
161.3
158.5
173.1
184.7
159.7
170.7
156.7
148.4
136.7
93.2
98.7
97.4
101.2
97.4
96.5
89.9
78.5
56.5

balance-sheet.row.property-plant-equipment-net

5826.81512.51262.71126.8
1011.5
909.4
822
855
778.3
721
705.8
711.7
669
593.6
554.8
577.1
531
481.7
384.7
328
283.8
255.7
223.3
210.3
235.8
227.6
220.3
202.2
210.3
229.3
192.2
172.8
165.8
165.8
201.3
178.8
169
155.5
125
97.5

balance-sheet.row.goodwill

430.9108.5107.3109.9
111.1
107.8
105.8
107.7
103
104.6
108.6
114.2
112.5
111.5
112.5
114.2
105.3
109.2
102.8
89.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

61.515.118.423
30.5
29.8
20.4
21.7
23.3
37.6
42
48.3
50.6
52
55.1
55.6
50
55
66.3
159.2
43.7
48.4
44.5
32.6
52.4
66.5
61.2
51.6
58.9
63
33.9
12.7
14.1
15
17.8
14.2
12.8
12.3
9
0

balance-sheet.row.goodwill-and-intangible-assets

492.4123.6125.7132.9
141.6
137.6
126.2
129.4
126.3
142.2
150.6
162.5
163.1
163.5
167.6
169.8
155.3
164.2
169.1
159.2
43.7
48.4
44.5
32.6
52.4
66.5
61.2
51.6
58.9
63
33.9
12.7
14.1
15
17.8
14.2
12.8
12.3
9
0

balance-sheet.row.long-term-investments

810.7210204.9207.7
214.7
192.7
91.2
85.8
82.7
61.3
60.6
60.9
59.8
56.2
48.2
38.2
33.6
31.7
29.7
27.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

13125.765.648.5
16
14
24.7
25.7
66.2
70.5
66.1
61.8
90.3
85.1
64.5
69.4
63.7
61
29.8
8.3
17.9
20.5
27.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

119.421.338.455.9
36.3
29
20.5
23.4
21.3
26.4
28.5
24
24.5
28.7
22.6
19.3
18.9
34.7
23.2
63.2
86.8
82.3
80.1
109.9
96.1
73
64.4
53.4
51.5
39.4
34.6
28.7
25.8
35
23.2
22.6
20.6
22.4
24.9
25

balance-sheet.row.total-non-current-assets

7380.31893.11697.31571.8
1420.1
1282.7
1084.6
1119.3
1074.8
1021.4
1011.6
1020.9
1006.7
927.1
857.7
873.8
802.5
773.3
636.5
586.4
432.2
406.9
375.5
352.8
384.3
367.1
345.9
307.2
320.7
331.7
260.7
214.2
205.7
215.8
242.3
215.6
202.4
190.2
158.9
122.5

balance-sheet.row.other-assets

0000
0
0
-386.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

14856.13829.53616.83313.8
2793.8
2341.4
1592.4
1862.8
1716.7
1695.1
1670.9
1671.6
1564
1399.1
1294.3
1271
1168.7
1185.6
918.2
823.6
658.7
623.6
536.8
511.3
557.4
551.8
505.6
477.9
477.4
480.1
397.4
307.4
304.4
313.2
343.5
313
298.9
280.1
237.4
179

balance-sheet.row.account-payables

920.3242.4215.4232.2
213.1
156.8
130.4
138.1
122
119.8
103.1
108
102.9
89.8
63.2
68.4
67.6
80.4
61.2
46.3
29.3
29.4
19.2
22.6
27.6
25.5
20.8
18.6
23.9
22.5
19.3
14.1
20.4
16.4
18
16.3
0
0
0
0

balance-sheet.row.short-term-debt

393.2151.718.253.5
12.4
11.9
0.1
102.5
2.4
69.3
27.2
2.2
32.7
50.1
0.3
0.5
3.9
0.5
0.5
0.3
10
8
15.8
8.7
3.6
29.6
36.1
1.6
2.9
9.8
21.9
7.7
10.6
9.3
12.3
6
6.3
9.2
14.6
4.4

balance-sheet.row.tax-payables

89.53138.539.3
41.4
12.9
9.8
6
4.5
12.8
14.9
22.1
23.4
17
15
13.8
9.7
9.8
1
3.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

840.5157.3299.7271.8
313.3
317.4
196
197
226.2
228.9
309.5
371.3
378.8
299.3
358.1
379.1
382.1
394.6
235.8
280.7
150.8
167
159.2
184.3
195.8
141.5
105
87.4
95.5
104.5
35.9
24.6
31.5
49.1
66.2
52.1
48.8
51.3
29.7
26

Deferred Revenue Non Current

145.148.22.169.4
80.4
52.5
56.2
53.4
75.6
62
83.7
83.1
135.4
126
87.2
85.1
86
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

57.3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

951.6236228.1259.7
226.9
145.4
127.7
20.5
103.4
110.8
108.9
43.3
43.5
39
42.9
41.5
34.7
61.4
1.6
78.2
0.7
81.5
52.7
18.8
48.1
48.9
47.3
37.8
38.8
29.5
45.1
25
29.9
45.2
34.4
24.7
37.2
35.5
28.3
11.9

balance-sheet.row.total-non-current-liabilities

1314.3276.7412.9384.3
435.9
426.6
298.9
303.4
358.2
356.9
461.5
528.3
573.3
501
498.9
520.8
522.5
511.8
342
361.2
241.1
247.1
247.6
259.2
272.3
215.8
170.7
141.8
159.5
164
81.9
61.6
64.8
81.2
91
77.2
84
79.6
55.6
43.2

balance-sheet.row.other-liabilities

0000
0
0
-386.5
-385.9
-370.6
-373
-377.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

405.6102.210972.3
70.5
72
0
0
0
0
0.2
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

3679.6948.5931.9978.4
939.3
768.2
196.1
197
228.6
298.2
336.7
765.2
835.1
744.2
668.6
691.9
681.6
694.7
498.9
486
357.6
366
335.3
334.5
351.6
319.8
274.9
199.8
225.1
225.8
168.2
108.4
125.7
152.1
155.7
124.2
127.5
124.3
98.5
59.5

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

75.218.818.818.8
18.8
18.8
18.8
18.8
18.4
18.1
17.8
17.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
4.3
4.3
4.3
4.3
4.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

138183523.42987.82456.7
1846.7
1549.4
1353.4
1178.2
1071.6
964.6
902.2
805
719.9
664.5
612.6
569.4
517.3
450.3
375.7
318.6
287.5
281.2
261.2
254
269.8
278.1
249.3
252.5
217.7
210.2
189.8
169.9
153.1
139.7
160.6
162.6
148.5
134.7
126.5
113.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

-742.6-143.8-183-159.6
-110.6
-149.6
-154.2
-117.3
-186.8
-162.6
-119.2
-32.4
-75.9
-71.5
-31.3
-19.7
-44.9
33.6
10.6
8.9
33.2
18.9
-13.4
-27.4
-14.5
-5.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

-1974.1-517.4-138.719.5
99.6
154.6
178.3
200.2
214.3
203.8
156.1
116.2
76.3
53.3
35.8
20.8
6.1
-7.2
19.6
-2.6
-28.2
-46.8
-50.6
-54.1
-54.8
-45.9
-19.2
25.2
34.3
43.9
37.5
18.2
15.5
13
15.5
17.1
22.9
21.1
12.4
6.1

balance-sheet.row.total-stockholders-equity

11176.528812684.92335.4
1854.5
1573.2
1396.3
1279.9
1117.5
1023.9
956.9
906.4
728.9
654.9
625.7
579.1
487.1
485.3
414.5
333.5
301.1
257.6
201.5
176.8
204.8
231.2
230.1
277.7
252
254.1
227.3
188.1
168.6
152.7
176.1
179.7
171.4
155.8
138.9
119.5

balance-sheet.row.total-liabilities-and-stockholders-equity

14856.13829.53616.83313.8
2793.8
2341.4
1592.4
1476.9
1346.1
1322.1
1293.6
1671.6
1564
1399.1
1294.3
1271
1168.7
1185.6
918.2
823.6
658.7
623.6
536.8
511.3
557.4
551.8
505.6
477.9
477.4
480.1
397.4
307.4
304.4
313.2
343.5
313
298.9
280.1
237.4
179

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
5.6
4.8
4.1
0
0
0
0
1
0.8
0.6
0.4
0.3
0.2
1.9
10.9
10.1
8.4
11.7
9.1
0
0
0
0

balance-sheet.row.total-equity

11176.528812684.92335.4
1854.5
1573.2
1396.3
1279.9
1117.5
1023.9
956.9
906.4
728.9
654.9
625.7
579.1
487.1
490.9
419.3
337.6
301.1
257.6
201.5
176.8
205.8
232
230.7
278.1
252.3
254.3
229.2
199
178.7
161.1
187.8
188.8
171.4
155.8
138.9
119.5

balance-sheet.row.total-liabilities-and-total-equity

14856.1---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

810.7210204.9207.7
214.7
192.7
91.2
85.8
82.7
61.3
60.6
68.4
72.2
56.2
48.2
38.2
37.9
21
29.7
27.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

1233.7309317.9325.3
325.7
329.3
196.1
197
228.6
298.2
336.7
373.5
411.5
349.4
358.4
379.6
386
395.1
236.3
281
160.8
175
175
193
199.4
171.1
141.1
89
98.4
114.3
57.8
32.3
42.1
58.4
78.5
58.1
55.1
60.5
44.3
30.4

balance-sheet.row.net-debt

-1916.9-544.9-576.4-437.3
-289.8
-109.8
-141.3
-38.9
25.6
23.6
81.4
143.5
249.6
257.6
248.2
296.5
298.8
286.7
189.2
232.2
92
137.2
141.8
150.9
156.7
125.8
109.8
36.7
71
96.9
30.6
27.1
39.1
55.7
76.3
56.5
50
47.8
36.9
21.9

现金流量表

在 West Pharmaceutical Services, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.057 的转变。该公司最近通过发行 51 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-368700000.000. 与上一年相比， 0.279 发生了变化. 在同一时期，公司记录了 137.3, -6.7 和 -2.3，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-57 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -0.1，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989

cash-flows.row.net-income

568.7593.4585.9661.8
346.2
241.7
206.9
150.7
143.6
95.6
127.1
112.3
80.7
75.5
65.3
72.6
86
70.7
67.1
45.6
19.4
31.9
18.4
19.6
1.6
38.7
6.7
44.4
16.4
28.7
27.3
22.5
19.7
-8.5
4.3
20.7

cash-flows.row.depreciation-and-amortization

141.3137.3120.6122.3
109.1
103.4
104.4
96.7
90.7
89.9
90
85.2
76.9
75.7
73.2
68.1
60.6
56.6
52.7
47.4
33.2
33
33
32
37
35.7
32.3
31.9
30.7
29.6
23.1
22
23.6
24.5
22.7
20.3

cash-flows.row.deferred-income-tax

-164.937.5-30.8-42.9
-5.8
15.3
0.9
41.7
21.5
-8.9
7
1.7
5.3
2.9
-1.8
-4.8
7.3
-6.4
4.9
2.3
-2.9
7.5
1.5
1.4
0.1
8.5
5.9
-7.5
-5.7
2
-2.7
2.5
0.6
-3.2
-2.6
-0.6

cash-flows.row.stock-based-compensation

19.823.323.737.5
34
24.4
15.1
16.1
19.5
29.6
18.6
21.2
15.5
8.4
7.8
7.5
6.4
11.8
0.9
0
10.9
0
0
-24.8
0
-9
0
-3.5
0.2
0.2
0.5
-1.4
0
26.1
-0.5
1.2

cash-flows.row.change-in-working-capital

-8.2-20.4-11.5-193.8
-10.3
-14.4
-28.3
-41.4
-58.7
-10.8
-30.6
-3.7
-3.3
-21.1
3
-15.6
-29.5
-14.5
-5.2
-20.4
1.9
12.7
-7.5
-15.1
4.9
-5.9
-0.3
2.8
-0.5
-15.7
-4.1
-6.3
-11.5
5.4
12.2
1.4

cash-flows.row.account-receivables

44-35.6-123.5
-46.6
-33.3
-43.8
-39.7
-23.3
-14.1
-6.3
-9.1
-25.7
-25.5
5.5
-6
1.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-13.5-13.5-49.8-86.5
-73.7
-18.6
-7
-3.6
-21.2
-11.4
-16.2
-13.9
-8.9
-9.3
-20.7
-6.4
-13.4
-9
-22.8
0.4
-6.9
-2.8
-4.7
-0.9
-0.5
-1.2
-2.4
2.7
-2.7
-4.5
-0.7
2.7
-4.5
10.4
3.3
-2.6

cash-flows.row.account-payables

9.54.4-2.816.8
36.6
25.3
0.4
12.6
6.1
17.2
-3.5
4.6
5.8
24.6
-0.3
-0.7
-3.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-8.2-15.376.7-0.6
73.4
12.2
22.1
-10.7
-20.3
-2.5
-4.6
14.7
25.5
-10.9
18.5
-2.5
-14.7
-5.5
17.6
-20.8
8.8
15.5
-2.8
-14.2
5.4
-4.7
2.1
0.1
2.2
-11.2
-3.4
-9
-7
-5
8.9
4

cash-flows.row.other-non-cash-items

199.35.436.1-0.9
-0.7
-3.2
-10.4
-0.5
2.8
17
-29.2
3.8
12.3
-10.7
-9.2
9.9
4.2
11
23.4
10.7
6.4
-15.9
8.5
19.6
5
1.4
26.4
-0.4
22.3
1.3
5.7
-0.8
1.6
0.1
-0.1
-0.1

cash-flows.row.net-cash-provided-by-operating-activities

756.6000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-370.5-362-284.6-253.4
-174.4
-126.4
-104.7
-130.8
-170.2
-131.6
-112.1
-155.8
-132
-96.8
-73.8
-107.8
-139.1
-129.4
-90.3
-54.1
-57.4
-60.8
-37.7
-44.1
-57.3
-63.4
-76.7
-34.4
-31.7
-31.3
-27.1
-33.5
-22.4
-25.5
-33.2
-34.3

cash-flows.row.acquisitions-net

000-2.2
0
-104
0
-6
0
0
112.1
155.8
132
96.8
-3.7
-16.9
-8.5
-4.7
0
-174.8
0
0
0
-1.1
-3.4
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
-85.1
0
0
-8.4
0
-9.3
-14.2
-31.2
-41.2
-7.2
107.8
139.1
-22.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
85.1
0
0
0
0
16.8
19.1
45.6
15.6
8.9
2.6
16.8
0.7
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

-6.7-6.7-3.62.5
-5.1
2.4
3.9
3.2
2.8
2.1
-111.5
-154.8
-130.4
-94.9
1.8
-107.6
-136.5
0.2
0.2
1.5
32.9
3.7
5.4
29.8
0.2
1.7
2.9
1.4
7.2
-69.3
-10.2
8
7.5
1
1.6
-5

cash-flows.row.net-cash-used-for-investing-activites

-377.2-368.7-288.2-253.1
-179.5
-228
-100.8
-133.6
-175.8
-129.5
-104
-149.9
-116
-120.5
-74
-121.9
-128.2
-155.9
-89.9
-227.4
-24.5
-57.1
-32.3
-15.4
-60.5
-61.7
-73.8
-33
-24.5
-100.6
-37.3
-25.5
-14.9
-24.5
-31.6
-39.3

cash-flows.row.debt-repayment

-2.3-2.3-44.3-2.2
-2.3
-136.4
-0.1
-34.9
-69.8
-98.8
-285.7
-341.5
-718.4
-200.4
-40.9
-10.2
-12.3
-137.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-15.2
0
-13
-1.5

cash-flows.row.common-stock-issued

52.55128.237.1
28.8
229
0
43.9
29.7
87.3
280.5
360.1
10.9
5.8
3.7
5
6.2
4.4
4.4
14.1
13.5
3
3.3
0.7
1.5
2.8
2.6
4
3.5
2.8
3.4
3.9
5.5
1.6
0.4
1.5

cash-flows.row.common-stock-repurchased

-652-451.2-222.2-151.9
-115.5
-83.1
-75.2
-78.2
-55.9
-5.6
-4.1
-5.2
-4.7
-3.5
-2.1
-1.3
-5.2
-43
0
-0.1
-0.1
0
-0.1
-0.1
-10.8
-18.1
-60.4
0
0
0
0
0
-3.3
0
-11.3
-5.3

cash-flows.row.dividends-paid

-57.6-57-54.1-51.1
-48.1
-45.1
-42.1
-39.1
-35.8
-32.4
-29.1
-26.8
-24.9
-23.2
-21.7
-20.1
-18.6
-17.5
-15.9
-14.1
-12.8
-11.8
-11.1
-10.5
-9.8
-10.3
-9.4
-9.4
-10
-8.1
-7.2
-7
-6.3
-6.2
-6.3
-5

cash-flows.row.other-financing-activites

-1.5-0.1-1.2-14.8
-89
-1.2
36.7
-0.7
17.9
8
7.6
8.3
733.7
196.6
27
4
9
278.2
-48.7
120.6
-16
-3.3
-25.1
-5.9
30.3
34.2
48.2
-1.7
-22.4
49.2
12.5
-7.6
0.5
-14.8
25.9
3.3

cash-flows.row.net-cash-used-provided-by-financing-activities

-659.6-459.6-293.6-168.1
-137.1
-36.8
-80.7
-109
-113.9
-41.5
-30.8
-5.1
-3.4
-24.7
-34
-22.6
-20.9
84.6
-60.2
120.5
-15.4
-12.1
-33
-15.8
11.2
8.6
-19
-7.1
-28.9
43.9
8.7
-10.7
-18.8
-19.4
-4.3
-7

cash-flows.row.effect-of-forex-changes-on-cash

-4.311.4-10.5-15.7
20.5
-0.7
-5.6
12.2
-1.3
-22.1
-22.8
2.6
2.1
-3.9
-3.2
2.7
-7.1
3.4
4.6
1.3
2
4.6
2.5
-2.1
-1.9
-2.3
0.8
-2.6
-0.1
0.8
0.8
-0.1
-19.1
-19.9
0.4
-0.1

cash-flows.row.net-change-in-cash

-953-40.4131.7147.1
176.4
101.7
101.5
32.9
-71.6
19.3
25.3
68.1
70.1
-18.4
27.1
-4.1
-21.2
61.3
-1.7
-20
31
4.6
-8.9
-0.6
-2.6
14
-21
25
9.9
-9.8
22
2.2
-18.8
-19.4
0.5
-3.5

cash-flows.row.cash-at-end-of-period

2482.1853.9894.3762.6
615.5
439.1
337.4
235.9
203
274.6
255.3
230
161.9
91.8
110.2
83.1
87.2
108.4
47.1
48.8
68.8
37.8
33.2
42.1
42.7
45.3
31.3
52.3
27.3
17.4
27.2
5.2
-16.1
-17.2
2.1
1.6

cash-flows.row.cash-at-beginning-of-period

3435.1894.3762.6615.5
439.1
337.4
235.9
203
274.6
255.3
230
161.9
91.8
110.2
83.1
87.2
108.4
47.1
48.8
68.8
37.8
33.2
42.1
42.7
45.3
31.3
52.3
27.3
17.4
27.2
5.2
3
2.7
2.2
1.6
5.1

cash-flows.row.operating-cash-flow

756.6776.5724584
472.5
367.2
288.6
263.3
219.4
212.4
182.9
220.5
187.4
130.7
138.3
137.7
135
129.2
143.8
85.6
68.9
69.2
53.9
32.7
48.6
69.4
71
67.7
63.4
46.1
49.8
38.5
34
44.4
36
42.9

cash-flows.row.capital-expenditure

-370.5-362-284.6-253.4
-174.4
-126.4
-104.7
-130.8
-170.2
-131.6
-112.1
-155.8
-132
-96.8
-73.8
-107.8
-139.1
-129.4
-90.3
-54.1
-57.4
-60.8
-37.7
-44.1
-57.3
-63.4
-76.7
-34.4
-31.7
-31.3
-27.1
-33.5
-22.4
-25.5
-33.2
-34.3

cash-flows.row.free-cash-flow

386.1414.5439.4330.6
298.1
240.8
183.9
132.5
49.2
80.8
70.8
64.7
55.4
33.9
64.5
29.9
-4.1
-0.2
53.5
31.5
11.5
8.4
16.2
-11.4
-8.7
6
-5.7
33.3
31.7
14.8
22.7
5
11.6
18.9
2.8
8.6

利润表行

West Pharmaceutical Services, Inc. 的收入与上期相比变化了 0.022%。据报告, WST 的毛利润为 1129.2。该公司的营业费用为 421.8，与上年相比变化了 4.873%. 折旧和摊销费用为 137.3，与上一会计期间相比变化了 0.138%. 营业费用报告为 421.8，显示4.873% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长-0.079%. 营业收入为 676，与上年相比变化了-0.079%. 净利润的变化率为 0.013%。去年的净收入为593.4.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985

income-statement-row.row.total-revenue

2928.62949.82886.92831.6
2146.9
1839.9
1717.4
1599.1
1509.1
1399.8
1421.4
1368.4
1266.4
1192.3
1104.7
1055.7
1051.1
1020.1
913.3
699.7
541.6
490.7
419.7
396.9
430.1
469.1
449.7
452.5
458.8
412.9
365.1
348.7
338.2
329.6
323.2
308.7
288.2
253.3
235.6
190.1

income-statement-row.row.cost-of-revenue

1840.51820.61750.71655.8
1379.1
1234.2
1172
1086.5
1008
944
973.6
933.7
878.7
853
786.6
752.1
748.5
728.3
651.5
507.1
385.7
334.9
302.1
280.8
289.7
289.1
282.2
288.5
302
265.1
225.9
222.1
217.8
221.4
221.5
206.7
197.4
174.4
160.2
128

income-statement-row.row.gross-profit

1088.11129.21136.21175.8
767.8
605.7
545.4
512.6
501.1
455.8
447.8
434.7
387.7
339.3
318.1
303.6
302.6
291.8
261.8
192.6
155.9
155.8
117.6
116.1
140.4
180
167.5
164
156.8
147.8
139.2
126.6
120.4
108.2
101.7
102
90.8
78.9
75.4
62.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

68.9---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-9.9326.87.9
12
2.4
4.8
-2
-27.7
-60.1
0.2
0.5
5.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.operating-expenses

426.1421.8402.2423.5
360.9
311.6
303.2
281.7
276.6
267.1
266
272.8
251.3
221.7
213.3
197.6
191.9
168.6
160.8
121.7
106.7
94.3
81
71.9
104.7
113.6
102.8
102.1
103.5
99.5
92.1
85.5
80.7
109.5
80.5
65.9
60.4
49
44.6
38.6

income-statement-row.row.cost-and-expenses

2266.62242.42152.92079.3
1740
1545.8
1475.2
1368.2
1284.6
1211.1
1239.6
1206.5
1130
1074.7
999.9
949.7
940.4
896.9
812.3
628.8
492.4
429.2
383.1
352.7
394.4
402.7
385
390.6
405.5
364.6
318
307.6
298.5
330.9
302
272.6
257.8
223.4
204.8
166.6

income-statement-row.row.interest-income

11.8285.11
1.4
3.8
2.1
1.3
1.1
1.6
3.5
1.9
1.8
1.3
0.6
0.8
1.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

8.497.97.2
6.8
4.7
6.3
6.5
7
12.5
13
15.1
14.9
18.2
16.8
14.4
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-10.9-28.4-54.1-3.4
-5.6
-4.8
4.8
-2
-27.7
-60.1
0.2
0.3
-12.9
-8
-14.1
-4.5
-1.2
-25.8
-8.9
-15
0.9
11.3
-8.6
-0.9
-19.3
1.3
-29.5
1.6
-19.1
2.4
-1.2
0.5
-5.7
1.1
-4.3
4.1
2.6
-2.2
2.3
3.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-9.9326.87.9
12
2.4
4.8
-2
-27.7
-60.1
0.2
0.5
5.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.total-operating-expenses

-10.9-28.4-54.1-3.4
-5.6
-4.8
4.8
-2
-27.7
-60.1
0.2
0.3
-12.9
-8
-14.1
-4.5
-1.2
-25.8
-8.9
-15
0.9
11.3
-8.6
-0.9
-19.3
1.3
-29.5
1.6
-19.1
2.4
-1.2
0.5
-5.7
1.1
-4.3
4.1
2.6
-2.2
2.3
3.2

income-statement-row.row.interest-expense

8.497.97.2
6.8
4.7
6.3
6.5
7
12.5
13
15.1
14.9
18.2
16.8
14.4
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

141.3137.3120.6126.1
110.3
103.3
104.4
96.7
90.7
89.9
90
85.2
76.9
75.7
73.2
68.1
60.6
56.6
52.7
47.4
33.2
33
33
32
37
35.7
32.3
31.9
30.7
29.6
23.1
22
23.6
24.5
22.7
20.3
18.9
16.8
14.7
12

income-statement-row.row.ebitda-caps

811.6---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

643.5676734752.3
406.9
296.6
240.3
228.9
196.8
128.6
182
162.4
135.1
109.6
90.7
97.5
124.1
94.9
101
72.2
48.2
54.5
26.7
41.3
35.7
66.4
64.7
61.9
53.3
48.3
47.1
41.1
39.7
-1.3
21.2
36.1
30.4
29.9
30.8
23.5

income-statement-row.row.income-before-tax

667.5698679.9748.9
401.3
291.8
240.7
222.4
189.8
116.1
169
147.1
108.6
92.7
74.5
83.1
109.5
86.4
84.5
45.2
41.2
47
17.2
27.8
3.1
57.1
27.9
57.7
27.2
42.6
40.7
36.8
34
-3.8
10.7
33.9
27.5
23.2
30.2
25.4

income-statement-row.row.income-tax-expense

115.1122.3114.7107.2
72.5
59
41.4
80.9
54.4
26.3
47.2
40.2
32.7
23.5
13.6
13.5
23.7
17.2
24.6
-0.4
11.1
16.7
4.1
8.6
1.5
18.4
21.2
13.3
10.8
13.9
13.4
14.3
14.3
4.7
6.4
13.2
10.1
9.5
13.2
10.4

income-statement-row.row.net-income

568.7593.4585.9661.8
346.2
241.7
206.9
150.7
143.6
95.6
127.1
112.3
80.7
75.5
65.3
72.6
86
70.7
67.1
45.6
19.4
31.9
18.4
-5.2
1.6
38.7
6.7
44.4
16.4
28.7
27.3
23.5
19.7
-8.5
4.3
20.7
17.4
13.7
17
15
类似股票
您可能还对以下内容感兴趣：
CNVVF
ConvaTec Group Plc.
3.2 USD
PNK
300753.SZ
Jiangsu Apon Medical Technology Co., Ltd..
12.59 CNY
SHZ
BLCO
Bausch + Lomb Corporation.
14.9 USD
NYSE
137310.KS
SD BioSensor, Inc.
10540 KRW
KSC
YPHDF
Ypsomed Holding AG.
362 USD
PNK
INFU
InfuSystem Holdings, Inc..
8.11 USD
AMEX
688289.SS
Sansure Biotech Inc..
20.67 CNY
SHH
7780.T
Menicon Co., Ltd..
1516.5 JPY
JPX
7741.T
HOYA Corporation.
18210 JPY
JPX
ALC.SW
Alcon Inc..
73.32 CHF
SIX
TARSONS.NS
Tarsons Products Limited.
437.6 INR
NSE

常见问题

什么是 West Pharmaceutical Services, Inc. (WST) 总资产是多少？

West Pharmaceutical Services, Inc. (WST) 总资产为 3829500000.000.

什么是企业年收入？

年收入为 1427400000.000.

企业利润率是多少？

公司利润率为 0.372.

什么是公司自由现金流？

自由现金流为 5.253.

什么是企业净利润率？

净利润率为 0.194.

企业总收入是多少？

总收入为 0.220.

什么是 West Pharmaceutical Services, Inc. (WST) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 593400000.000.

公司总债务是多少？

债务总额为 309000000.000.

营业费用是多少？

运营支出为 421800000.000.

公司现金是多少？

企业现金为 601800000.000.